Panel Small Biopharma Strategies track
Trial Planning for Small- & Mid-Sized Biotechs: Free of Legacy Systems and Processes—But Short on Time and Money
Tue, Feb 4, 2025 · 3:40–4:10 PM EST Rosen Shingle Creek
About this session
Panel Discussion.
Each clinical trial is unique. However, something small- and mid-sized biopharma companies have in common is the need to plan and execute trials in a way that does not mimic the contracts, budgets, and processes of typical bigger pharma and CRO partners. The smaller players often have a small clinical team and they want a CRO that understands their needs and knows how they are different. These smaller companies have the freedom to innovate—what to outsource and when, what capabilities and functions to build and why, who to partner with and how to find them, etc., but with this freedom comes the burden of creating on the go.
Speakers
-
Vice President, Clinical Operations · Secretome Therapeutics
Panelist
